<DOC>
	<DOCNO>NCT01868802</DOCNO>
	<brief_summary>A randomized multicentric parallel arm study involve use ketamine treatment-resistant depression hold three national health provider clinic Mexican population . The purpose study determine whether clinical response see previous study replicable population .</brief_summary>
	<brief_title>Ketamine Treatment-resistant Depression : A Multicentric Clinical Trial Mexican Population</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Age : 1865 year old Mayor Depressive Disorder Diagnosis base DSMIV TR . Classification MDD treatmentresistant . No brain structural abnormality evidence MRI scan . Signed acceptance Informed Consent . Other psychiatric diagnosis apart MDD . Substance abuse dependence ( prior study ) . Pregnancy . Congestive heart disease . Personal history psychosis . Firstdegree relative history psychosis . Glaucoma . Present neurological disease . High blood pulmonary artery pressure . Declining sign informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Ketamine</keyword>
	<keyword>Depression</keyword>
	<keyword>Depressive Disorder</keyword>
</DOC>